- Home
- OBT vs ZURA Comparison
OBT vs ZURA Comparison
Compare OBT & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBT | ZURA |
|---|---|---|
| Founded | 1892 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.1M | 252.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OBT | ZURA |
|---|---|---|
| Price | $28.79 | $3.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $31.00 | $11.38 |
| AVG Volume (30 Days) | 25.4K | ★ 359.5K |
| Earning Date | 10-29-2025 | 11-13-2025 |
| Dividend Yield | ★ 1.81% | N/A |
| EPS Growth | ★ 18.38 | N/A |
| EPS | ★ 3.03 | N/A |
| Revenue | ★ $115,418,000.00 | N/A |
| Revenue This Year | $19.86 | N/A |
| Revenue Next Year | $7.20 | N/A |
| P/E Ratio | $9.48 | ★ N/A |
| Revenue Growth | ★ 17.75 | N/A |
| 52 Week Low | $20.97 | $0.97 |
| 52 Week High | $30.40 | $4.68 |
Technical Indicators
Market Signals| Indicator | OBT | ZURA |
|---|---|---|
| Relative Strength Index (RSI) | 71.02 | 58.62 |
| Support Level | $27.00 | $3.58 |
| Resistance Level | $29.31 | $3.94 |
| Average True Range (ATR) | 0.77 | 0.24 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 81.93 | 95.69 |
Price Performance
Historical ComparisonAbout OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.